The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carcinosarcoma


High impact information on Carcinosarcoma

  • Response of Walker 256 carcinosarcoma cells to 12-O-tetradecanoylphorbol 13-acetate: possible regulation by endogenous cyclooxygenase metabolites [5].
  • Antitumor activity of a polychlorinated biphenyl mixture, Aroclor 1254, in rats inoculated with Walker 256 carcinosarcoma cells [6].
  • Rat Walker 256 (W256) carcinosarcoma cells express 12-LOX and synthesize 12(S)- and 15(S)-hydroxyeicosatetraenoic acids as their major LOX metabolites [7].
  • The present studies demonstrate that cleavage of C5a with trypsin generates a derivative peptide that is chemotactic for tumor cells (Walker carcinosarcoma) [8].
  • Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone [9].

Chemical compound and disease context of Carcinosarcoma


Biological context of Carcinosarcoma


Anatomical context of Carcinosarcoma


Gene context of Carcinosarcoma


Analytical, diagnostic and therapeutic context of Carcinosarcoma


  1. A unique complement derived chemotactic factor for tumor cells. Romualdez, A.G., Ward, P.A. Proc. Natl. Acad. Sci. U.S.A. (1975) [Pubmed]
  2. C-type virus particles in urethan-induced pulmonary and renal carcinomas, in cell-graft-transmitted carcinosarcomas, and in filtrate-induced lymphomas in mice. Gross, L., Feldman, D., Dreyfuss, Y., Ehrenreich, T., Moore, L.A. Cancer Res. (1976) [Pubmed]
  3. Effects of prostacyclin on tumor cell-induced platelet aggregation. Menter, D.G., Onoda, J.M., Taylor, J.D., Honn, K.V. Cancer Res. (1984) [Pubmed]
  4. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Hiesiger, E.M., Voorhies, R.M., Basler, G.A., Lipschutz, L.E., Posner, J.B., Shapiro, W.R. Ann. Neurol. (1986) [Pubmed]
  5. Response of Walker 256 carcinosarcoma cells to 12-O-tetradecanoylphorbol 13-acetate: possible regulation by endogenous cyclooxygenase metabolites. Varani, J., Perone, P. J. Natl. Cancer Inst. (1985) [Pubmed]
  6. Antitumor activity of a polychlorinated biphenyl mixture, Aroclor 1254, in rats inoculated with Walker 256 carcinosarcoma cells. Kerkvliet, N.I., Kimeldorf, D.J. J. Natl. Cancer Inst. (1977) [Pubmed]
  7. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Tang, D.G., Chen, Y.Q., Honn, K.V. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  8. Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5. Orr, W., Phan, S.H., Varani, J., Ward, P.A., Kreutzer, D.L., Webster, R.O., Henson, P.M. Proc. Natl. Acad. Sci. U.S.A. (1979) [Pubmed]
  9. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone. Waki, Y., Nomura, M., Kasugai, S., Ohya, K., Miyamoto, K. Cancer Res. (1999) [Pubmed]
  10. Cisplatin in gynecologic carcinosarcoma. Willemse, P.H., Bouma, J., Hollema, H. J. Clin. Oncol. (1992) [Pubmed]
  11. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery. Zou, Y., Yamagishi, M., Horikoshi, I., Ueno, M., Gu, X., Perez-Soler, R. Cancer Res. (1993) [Pubmed]
  12. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat. Kooistra, K.L., Rodriguez, M., Powis, G. Cancer Res. (1989) [Pubmed]
  13. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Wada, H., Enomoto, T., Fujita, M., Yoshino, K., Nakashima, R., Kurachi, H., Haba, T., Wakasa, K., Shroyer, K.R., Tsujimoto, M., Hongyo, T., Nomura, T., Murata, Y. Cancer Res. (1997) [Pubmed]
  14. Binding of formyl peptides to Walker 256 carcinosarcoma cells and the chemotactic response of these cells. Rayner, D.C., Orr, F.W., Shiu, R.P. Cancer Res. (1985) [Pubmed]
  15. Endothelial cell damage by Walker carcinosarcoma cells is dependent on vitronectin receptor-mediated tumor cell adhesion. Shaughnessy, S.G., Lafrenie, R.M., Buchanan, M.R., Podor, T.J., Orr, F.W. Am. J. Pathol. (1991) [Pubmed]
  16. Diacylglycerols and the protein kinase inhibitor H-7 suppress cell polarity and locomotion of Walker 256 carcinosarcoma cells. Keller, H.U., Zimmermann, A., Niggli, V. Int. J. Cancer (1989) [Pubmed]
  17. Tumor visualization with a radioiodinated phospholipid ether. Counsell, R.E., Schwendner, S.W., Meyer, K.L., Haradahira, T., Gross, M.D. J. Nucl. Med. (1990) [Pubmed]
  18. Influence of interleukin-2 infusion on cell cycle kinetics in the Walker-256 carcinosarcoma. Wan, J.M., Bistrian, B.R., Figoni, M.A., Istfan, N.W. J. Leukoc. Biol. (1994) [Pubmed]
  19. Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumor cell survival. Tang, D.G., Honn, K.V. J. Cell. Physiol. (1997) [Pubmed]
  20. Pulmonary blastoma, carcinosarcoma and spindle-cell carcinoma: an immunohistochemical study of keratin intermediate filaments. Addis, B.J., Corrin, B. J. Pathol. (1985) [Pubmed]
  21. Angiogenesis in carcinosarcomas of the uterus: differences in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements. Emoto, M., Iwasaki, H., Ishiguro, M., Kikuchi, M., Horiuchi, S., Saito, T., Tsukamoto, N., Kawarabayashi, T. Hum. Pathol. (1999) [Pubmed]
  22. O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts. Clemons, M., Kelly, J., Watson, A.J., Howell, A., McElhinney, R.S., McMurry, T.B., Margison, G.P. Br. J. Cancer (2005) [Pubmed]
  23. Carcinosarcoma of the renal pelvis with extension into the renal vein and inferior vena cava. Tarry, W.F., Morabito, R.A., Belis, J.A. J. Urol. (1982) [Pubmed]
  24. Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: evidence for monoclonal origin. Sonoda, Y., Saigo, P.E., Federici, M.G., Boyd, J. Gynecol. Oncol. (2000) [Pubmed]
  25. Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. Fleischmann, A., Waser, B., Gebbers, J.O., Reubi, J.C. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  26. Localization of the VEGF and angiopoietin genes in uterine carcinosarcoma. Emoto, M., Charnock-Jones, D.S., Licence, D.R., Ishiguro, M., Kawai, M., Yanaihara, A., Saito, T., Hachisuga, T., Iwasaki, H., Kawarabayashi, T., Smith, S.K. Gynecol. Oncol. (2004) [Pubmed]
  27. MDM2 and CDK4 expression in carcinosarcoma of the esophagus: comparison with squamous cell carcinoma and review of the literature. Nikitakis, N.G., Drachenberg, C.B., Papadimitriou, J.C. Exp. Mol. Pathol. (2002) [Pubmed]
  28. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat. Moore, D.J., Powis, G., Richardson, R.L., Pittelkow, M.R. Cancer Res. (1985) [Pubmed]
  29. The chemotactic response of tumor cells. A model for cancer metastasis. Lam, W.C., Delikatny, E.J., Orr, F.W., Wass, J., Varani, J., Ward, P.A. Am. J. Pathol. (1981) [Pubmed]
  30. Changes in brain amines associated with cancer anorexia. Chance, W.T., von Meyenfeldt, M.F., Fischer, J.E. Neuroscience and biobehavioral reviews. (1983) [Pubmed]
  31. Distinct cadherin profiles in special variant carcinomas and other tumors of the breast. Han, A.C., Soler, A.P., Knudsen, K.A., Salazar, H. Hum. Pathol. (1999) [Pubmed]
  32. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Sutton, G., Kauderer, J., Carson, L.F., Lentz, S.S., Whitney, C.W., Gallion, H. Gynecol. Oncol. (2005) [Pubmed]
WikiGenes - Universities